Table 1 |
||||||||||
|
Effect of IFN-β treatment on retroviral restriction. |
||||||||||
|
FOLD RESTRICTION |
||||||||||
|
|
||||||||||
|
HIV-1 |
N-MLV |
NB-MLV |
B-MLV |
SIVmac |
||||||
|
MOI |
0.5 |
5 |
0.5 |
5 |
0.5 |
5 |
0.5 |
5 |
0.5 |
5 |
|
|
||||||||||
|
MDTF |
1.2 |
1.0 |
1.0 |
1.1 |
1.1 |
1.0 |
1.1 |
1.1 |
1.1 |
1.0 |
|
HeLa |
1.5 |
1.1 |
3.7 |
7.6 |
1.9 |
1.4 |
nt |
nt |
nt |
nt |
|
CMMT |
2.8 |
1.2 |
1.1 |
1.0 |
1.1 |
1.1 |
nt |
nt |
nt |
nt |
|
Vero |
1.2 |
1.3 |
4.4 |
8.8 |
1.5 |
1.2 |
nt |
nt |
nt |
nt |
|
OMK |
2.9 |
26.1 |
5.6 |
3.9 |
5.6 |
5.5 |
2.1 |
3.9 |
1.1 |
1.1 |
|
|
||||||||||
|
HeLa, CMMT, Vero or OMK cells were stimulated with IFN-β and transduced 24 h later at a MOI of 0.5 or 5 (as determined on MDTF cells) with HIV-1, N-MLV, NB-MLV, B-MLV or SIVmac, as indicated. The same experiment was performed in parallel on MDTF cells treated or not with universal type I IFN. Fold restriction represents the ratio of untreated to IFN-treated cells to be transduced by the GFP-encoding retroviral vectors. A significant enhancement of retroviral restriction is defined as a ratio > 2 (in bold). Data are from a typical experiment representative of three independent experiments. nt: not tested. |
||||||||||
|
Carthagena et al. Retrovirology 2008 5:59 doi:10.1186/1742-4690-5-59 |
||||||||||